Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort ascending
May
27
2021
Spotlight on Upcoming Oral Arguments – June 2021 Finnegan
Jun
17
2021
Applicant’s Unreasonable Delays During Patent Prosecution Can Lead to Prosecution Laches Finnegan
Aug
25
2021
Intrinsic Evidence Seals the Deal for Seabed Finnegan
Aug
30
2021
IPR, CBM, and PGR Statistics for Final Written Decisions Issued in June and July 2021 Finnegan
Sep
7
2021
File It or Lose It Finnegan
Sep
15
2021
Prosecution Pointers 286-294 Finnegan
Dec
17
2021
Fintiv Factors 2 and 4 Save Petitioner’s Request for Rehearing Finnegan
Dec
30
2021
Federal Circuit PTAB Appeal Statistics Through November 30, 2021 Finnegan
Jan
25
2022
Federal Circuit Reverses District Court’s Narrow Claim Construction Ruling Finnegan
Feb
16
2020
A Practical Guide to the Trademark Modernization Act of 2020 Finnegan
Feb
24
2021
Recoup Your Investment and More – Your Equitable Intervening Rights Are Safe Finnegan
Feb
26
2021
RCE Costs Patentee Nearly Two Years of PTA Finnegan
Apr
1
2021
Spotlight on Upcoming Oral Arguments – April 2021 Finnegan
Apr
12
2021
Unexpected Results Should Be Commensurate with the “Full Scope” of the Claims Finnegan
May
10
2021
Part 1: Prosecution History in Claim Interpretation Finnegan
Jun
11
2021
Supremely Confusing on That Complex Word “A”; Is It Only One or Is It One or More? Finnegan
Aug
13
2021
Objective Indicia: Nexus Analysis May Require Evaluation of Claims as a “Unique Combination” Finnegan
Aug
25
2021
Spotlight on Upcoming Oral Arguments – September 2021 Finnegan
Sep
2
2021
Federal Circuit Upholds Exclusion of Damages Expert Testimony Finnegan
Nov
4
2021
USPTO Director Grants First Director Review Petition, Vacating PTAB Decision Finnegan
Jan
3
2022
The Virtues of Claiming Precisely What the FDA Approved! Finnegan
Jan
19
2022
Provisional Application of UPC Agreement Goes Into Effect Finnegan
Feb
10
2022
Skater Can’t Land Lanham Act Complaint Against Video Game Finnegan
Feb
26
2021
Spotlight on Upcoming Oral Arguments - March 2021 Finnegan
Apr
7
2021
Federal Circuit Confirms the PTAB’s Authority to Deinstitute IPR Proceedings Finnegan
Apr
26
2021
Spotlight on Upcoming Oral Arguments – May 2021 Finnegan
Jun
29
2021
TTAB Trims Monster’s Claws by Dismissing Opposition Against Toronto Raptors Logo Finnegan
Jul
22
2021
Iced Out: Use of Ice Cube’s Image and Catchphrase Was Not Endorsement Finnegan
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins